Publications & Works

Publication Network
Journal articles indexed in SCI, SSCI, and AHCI

Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity

GÖZELLE M., KAYA S. G., AKSEL A. B., Ozkan E., Bakar-Ates F., ÖZKAN Y., et al.
Bioorganic Chemistry , vol.123, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

Synthesis of N '-(4-/3-/2-/Non-substituted benzylidene)-4-[(4-methylphenyl)sulfonyloxy] Benzohydrazides and Evaluation of Their Inhibitory Activities against Monoamine Oxidases and beta-Secretase

SELLİTEPE H. E., Oh J. M., DOĞAN İ. S., YILDIRIM S., AKSEL A. B., Jeong G. S., et al.
APPLIED SCIENCES-BASEL , vol.11, no.13, 2021 (SCI-Expanded) identifier identifier

Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT

Yagci S., GÖZELLE M., KAYA S. G., ÖZKAN Y., Aksel A. B., Bakar-Ates F., et al.
BIOORGANIC & MEDICINAL CHEMISTRY , vol.30, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences

The potential of 3-(4-((4-fluorophenyl(carbonyl/sulfonyl)piperazin-1-yl)-1-(3,4,5- trimethoxyphenyl)propan-1-one as a new scaffold for tubulin inhibition: in silico approach guided by molecular docking and synthesis studies

Zıvalı H., Aksel A. B., Impram Z., Polat A., Doğan İ. S.
7th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2024), Ankara, Turkey, 2 - 04 October 2024, pp.596-597, (Full Text)

NOVEL 2-MORPHOLINOMETHYL-BENZIMIDAZOLE-1-SULFONAMIDE/ CARBOXAMIDE AS CARBONIC ANHYDRASE İNHIBITORS: SYNTHESIS, STRUCTURE CHARACTERIZATION AND MOLECULAR DOCKING STUDIES AGAINST İSOFORMS I, II, IX AND XII

Aksel A. B., Alemdar A., Yazıcı Y., Doğan İ. S.
14th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 25 - 28 June 2024, pp.199, (Summary Text)

(4-HYDROXYPHENYL)-4-METHYL-1-((4- SUBSTITUEPHENYLAMINO)METHYL)-3H-1,2,4- TRIAZOLE-3-THIONE DERIVATIVES AS INHIBITORS OF MONOAMINE OXIDASE

Sellitepe H. E., Zıvalı H., Aksel A. B., Sağlık Özkan B. N., Doğan İ. S.
"International Multidisciplinary Symposium on Drug Research and Development (DRD) 2023, İzmir, Turkey, 4 - 06 May 2023, pp.188, (Summary Text)

N-(5-(3-Methoxybenzyl/pyrimidin-2-yl-methyl)-1,3,4- oxadiazol-2-yl)-2-(arylthio)acetamide Derivatives as SIRT2 Inhibitors

Aksel A. B., Eren G., Özkan Y.
9th EFMC Young Medicinal Chemists' Symposium, Nice, France, 8 - 09 September 2022, pp.10, (Summary Text)

“N-(5-arylmethyl-1,3,4-oxadiazole-2-yl)-2-(arylthio)acetamide as a new scaffold for developing small-molecule SIRT inhibitors”

Aksel A. B., Eren G., Özkan Y.
3rd International Gazi Pharma Symposium Series, Ankara, Turkey, 8 - 10 September 2021, pp.133, (Summary Text)

SYNTHESIS OF NOVEL HYDRAZONE DERIVATIVES AND EVALUATION OF THEIR INHIBITORY ACTIVITIES AGAINST MONOAMINE OXIDASES AND β-SECRETASE

Sellitepe H. E., Aksel A. B.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, pp.84, (Full Text)
Books

Epidermal Büyüme Faktör Reseptör İnhibitörlerinin Kanser Tedavisindeki Rolleri

Aksel A. B., Zıvalı H., Doğan İ. S.
in: Sağlık Bilimleri Alanında Gelişmeler, Prof. Dr. Salim Güngör, Editor, Platanus Yayın Grubu, Ankara, pp.195-235, 2023
Metrics

Publication

10

Citation (WoS)

12

H-Index (WoS)

3

Citation (Scopus)

14

H-Index (Scopus)

3

Project

7
UN Sustainable Development Goals